[topsearch__bar__shortcode]

April 12, 2022

CYTO

Altamira Therapeutics Ltd. (CYTO) Under Corrections Premarket After Huge Uptick on Covid-19 Nasal Spray Data

Yesterday, Altamira Therapeutics Ltd. (CYTO) saw a huge uptick after it announced the publication of its Covid-19 nasal spray data in IJMS. The stock rallied by over 55% in the regular trading session to mark the close of the day at $1.66 apiece. In today’s premarket session on April 12, CYTO has succumbed to corrections […]

Altamira Therapeutics Ltd. (CYTO) Under Corrections Premarket After Huge Uptick on Covid-19 Nasal Spray Data Read More »

BDSX

Biodesix Inc. (BDSX) Skyrockets After Hours on Stock Purchase by Chairman and Certain Directors

The lung disease-focused diagnostic company, Biodesix Inc. (BDSX) stock while suffering a decline in regular trading on Monday, skyrocketed in the after hours. The downfall was a result of the company’s announcement of a private placement and an amendment to its term loan. But thankfully, the SEC filings regarding stock purchases by certain board members

Biodesix Inc. (BDSX) Skyrockets After Hours on Stock Purchase by Chairman and Certain Directors Read More »

AGLE

Aeglea BioTherapeutics Inc. (AGLE) Surges After Hours on Additional Data for Rare Disorder Presentation

On April 11, Aeglea BioTherapeutics Inc. (AGLE) stock rallied by nearly 28% in the after-hours trading at a heavy shares traffic of 1.28 million. Thus, the stock surged up to $3.11 a share in the session after it closed the prior session at $2.43 with a decline of 6.54%. The reason for the after-hours rally

Aeglea BioTherapeutics Inc. (AGLE) Surges After Hours on Additional Data for Rare Disorder Presentation Read More »

ATHX Stock

Athersys Inc. (ATHX) Rebounds Only to Fall Once Again. What’s Going on?

On April 11, Athersys Inc. (ATHX) stock rebounded after a long fall to increase by 63.00% during the regular trading session. But the uptrend could not last any longer as the stock fell under corrections in the after-hours to shed 11.51%. Thus, after reaching $0.8600 in regular trading, ATHX plunged down to $0.7610 in the

Athersys Inc. (ATHX) Rebounds Only to Fall Once Again. What’s Going on? Read More »

PTE stock

PolarityTE Inc. (PTE) stock Bounces Back After Hours Following its Descent to New Low

The regenerative tissue and biomaterials developer, PolarityTE Inc. (PTE) finally made a comeback in the after-hours on April 11, 2022. The stock had been in a long downtrend which culminated in its new 52-week in the prior session. Thus, after closing the regular session near the new low, PTE rebounded and rose by 42.67% in

PolarityTE Inc. (PTE) stock Bounces Back After Hours Following its Descent to New Low Read More »

HOTH stock

Hoth Therapeutics Inc. (HOTH) Rally on HT-KIT’s Cancer Response Cut Short by Propose Offering After Hours

Hoth Therapeutics Inc. (HOTH) had meme-like trading on April 11, 2022. The biopharmaceutical company released development updates for its novel cancer therapeutic, HT-KIT which prevented cancer cell growth. The positive data caused an upswing by a huge 70.48% in HOTH stock during regular trading. Consequently, the stock reached a value of $1.05 at the end

Hoth Therapeutics Inc. (HOTH) Rally on HT-KIT’s Cancer Response Cut Short by Propose Offering After Hours Read More »

VERU stock

Veru Inc. (VERU) Remains Bullish on Game Changing Covid-19 Treatment Candidate

On April 11, Veru Inc. (VERU) announced game-changing clinical study results for its Covid-19 oral drug candidate, sabizabulin. Consequently, investors rallied towards the stock to make it soar by a mammoth 182.30% during the regular session. Continuing its bullishness into the after-hours, VERU reached $13.95 after closing the prior session at $12.28. Thus, the stock

Veru Inc. (VERU) Remains Bullish on Game Changing Covid-19 Treatment Candidate Read More »